Clinical Trial Update: Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Update on a completed Phase 1/2 trial evaluating an intradermal stabilized tumor mRNA vaccine in patients with malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Stabilized tumor mRNA vaccine

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED